Drugs / endometrial cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05455151 | Oct 2018 → Jan 2021 | uterine disorder | Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | endometrial cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05455151 ↗ |
| Modality | Cell therapy | “Group 4 (n=5) received injections of the minimally manipulated autologous endometrial cells suspended in autologous PRP.” NCT05455151 ↗ |
| Route | Other | “received injections of the minimally manipulated autologous endometrial cells suspended in autologous PRP” NCT05455151 ↗ |